Howard Frumin
Clinical Cardiac Electrophysiology · Laguna Hills, CANPI 1649377334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 353 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 38 manufacturers reported payments, led by Biotronik Inc. at 33.7% of the total. Reporting peaked in 2021 at $2,608 and has fallen 95.2% since, to $124 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CA, where the typical reported total is $26,911.
Across 353 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$608
- Novartis$509
- Acutus Medical, Inc.$407
- Boston Scientific$364
- Sanofi-aventis U.S. LLC$359
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,27699%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 41 | $3,158 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 31 | $608 |
| Novartis | 34 | $509 |
| Acutus Medical, Inc. | 5 | $407 |
| Boston Scientific | 16 | $364 |
| Sanofi-aventis U.S. LLC | 19 | $359 |
| Boehringer Ingelheim | 13 | $277 |
| Merck | 14 | $271 |
| Abbott | 18 | $268 |
| Amgen | 13 | $264 |
| Johnson & Johnson | 22 | $246 |
| Impulse Dynamics (USA) Inc. | 11 | $220 |
| Esperion Therapeutics, Inc. | 12 | $203 |
| E.r. Squibb & Sons, L.L.C. | 13 | $197 |
| Cvrx, Inc. | 6 | $190 |
| Novo Nordisk | 9 | $182 |
| Alnylam Pharmaceuticals Inc. | 7 | $166 |
| Pfizer | 7 | $158 |
| Regeneron Healthcare Solutions, Inc. | 7 | $142 |
| Atricure, Inc. | 1 | $131 |
| Amarin Pharma, Inc. | 7 | $130 |
| Biosense Webster, Inc. | 3 | $118 |
| Astellas Pharma US Inc | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Tactile Systems Technology Inc | 6 | $87 |
| Arbor Pharmaceuticals, Inc. | 4 | $79 |
| Kestra Medical Technology Services, Inc. | 4 | $69 |
| Bayer | 3 | $62 |
| Gilead | 4 | $58 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $39 |
| Chiesi USA, Inc. | 2 | $37 |
| Medtronic | 2 | $33 |
| Scpharmaceuticals Inc. | 2 | $32 |
| Bardy Diagnostics, Inc. | 2 | $25 |
| Preventice Services, LLC | 1 | $21 |
| Infobionic, Inc | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $15 |
| Itamar Medical Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rivacor$421
- BioMonitor$421
- Solia$421
- Edora$421
- Acticor$421
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$131
- Barostim Neo System$101
How this compares
$9,359 in reported general payments places this provider in the 20th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $53,783 |
| XareltoRivaroxaban | 28 | $35,429 |
| JardianceEmpagliflozin | 11 | $6,611 |
| Amiodarone Hcl | 34 | $1,763 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $736 |
| Metoprolol Succinate | 29 | $549 |
| Olmesartan Medoxomil | 30 | $475 |
| Rosuvastatin Calcium | 13 | $321 |
| Carvedilol | 12 | $132 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 11 | $92 |
| Furosemide | 14 | $50 |
| Amlodipine Besylate | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $158 | $53,78347 claims |
| Johnson & JohnsonXarelto | $246 | $35,42928 claims |
| Boehringer IngelheimJardiance | $277 | $6,61111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Laguna Hills
- Ashish ShahLaguna Hills$103K
- Shephal DoshiSanta Monica$2.1M
- Jonathan HsuSan Diego$1.2M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Nicholas Olsonla Jolla$801K
- Jonathan DukesVentura$775K
- Brett GidneySanta Barbara$756K
- John Rogersla Jolla$738K
- Rajesh BankerNewport Beach$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.